CANBRIDGE PHARM.DL-00001 (MF1) — Defensive Interval Ratio
CANBRIDGE PHARM.DL-00001 (MF1) has a Defensive Interval Ratio of 12 days as of December 2025. Defensive assets of €15.12 Million (cash €-, short-term investments €-, receivables €15.12 Million) cover 12 days of daily cash needs of €1.25 Million/day. Check MF1 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
CANBRIDGE PHARM.DL-00001 Defensive Interval Ratio (2021–2025)
This chart shows how CANBRIDGE PHARM.DL-00001's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 12 days, meaning defensive assets of €15.12 Million can fund 12 days of operations without new revenue. Also explore MF1 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for CANBRIDGE PHARM.DL-00001 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for CANBRIDGE PHARM.DL-00001 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see CANBRIDGE PHARM.DL-00001 market cap and net worth.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 12 days | €15.12 Million | €1.25 Million/day | €- | €- | ▼ -1 days |
| 2024 | 13 days | €16.72 Million | €1.32 Million/day | €- | €- | ▼ -22 days |
| 2023 | 35 days | €31.23 Million | €898.48K/day | €- | €- | ▲ +10 days |
| 2022 | 25 days | €19.05 Million | €761.93K/day | €- | €- | ▲ +7 days |
| 2021 | 18 days | €9.14 Million | €508.99K/day | €- | €- | — |